Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

EU digital strategy requires investments in the digitalisation of Europe’s medicines regulatory agencies to succeed

15 January 2021

Open

EU Pharma Strategy: Success depends on access to Generic, Biosimilar and Value Added Medicines

25 November 2020

Open

Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines

5 November 2020

Open

Statement from the President: Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing

7 October 2020

Berlin, 07 October 2020, speaking at ‘For a Healthy Europe’, […]

Read more

COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy

9 July 2020

Urgent call for a structured industry-EU dialogue on reform The […]

Read more

EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from Covid19

4 June 2020

Open

Letter to EU Trade Ministers. European Industry trade and supply chain needs to respond to Covid-19

10 April 2020

Open

A statement from the President on COVID-19

8 April 2020

Open

Medicines for Europe welcomes European Commission decision to enable secure supply of hospital medicines

8 April 2020

Open

Statement: Supply of essential ICU medicines

2 April 2020

Open

Subscribe to our newsletter